| Phase 1-2 Trial HCQ Plus TACE in Unresectable HCC (NCT02013778) | Abramson Cancer Center at Penn Medicine | 2013-11-01 |
| Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients (NCT01994850) | Abramson Cancer Center at Penn Medicine | 2013-11-01 |
| Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer (NCT02530008) | Abramson Cancer Center at Penn Medicine | 2013-10-01 |
| Suitability of DCE-MRI for Detection of Vascular Changes After VBT (NCT01991808) | Abramson Cancer Center at Penn Medicine | 2013-10-01 |
| Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer (NCT02830282) | Abramson Cancer Center at Penn Medicine | 2013-07-01 |
| A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas (NCT01985958) | Abramson Cancer Center at Penn Medicine | 2013-07-01 |
| TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients (NCT01918683) | Abramson Cancer Center at Penn Medicine | 2013-07-01 |
| Ovarian Tissue Transplantation (NCT01870752) | Abramson Cancer Center at Penn Medicine | 2013-06-01 |
| A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma (NCT01897116) | Abramson Cancer Center at Penn Medicine | 2013-06-01 |
| Study Of Circulating Multiple Myeloma Cells As A Biomarker of MGUS And SMM (NCT01958528) | Abramson Cancer Center at Penn Medicine | 2013-05-23 |
| HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck Cancer (NCT01984359) | Abramson Cancer Center at Penn Medicine | 2013-05-01 |
| APBI Proton Feasibility and Phase II Study (NCT01839838) | Abramson Cancer Center at Penn Medicine | 2013-04-22 |
| CTCs for High Grade Glioma (NCT02558335) | Abramson Cancer Center at Penn Medicine | 2013-04-01 |
| A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma (NCT01839799) | Abramson Cancer Center at Penn Medicine | 2013-04-01 |
| A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate Cancer (NCT02135653) | Abramson Cancer Center at Penn Medicine | 2013-03-01 |
| Proton Therapy for High Risk Prostate Cancer (NCT01811810) | Abramson Cancer Center at Penn Medicine | 2013-03-01 |
| Yoga for Breast Cancer (NCT01985945) | Abramson Cancer Center at Penn Medicine | 2013-03-01 |
| Multiple Myeloma and Exercise (NCT01809717) | Abramson Cancer Center at Penn Medicine | 2013-03-01 |
| Phase II Maraviroc for GVHD Prevention (NCT01785810) | Abramson Cancer Center at Penn Medicine | 2013-02-01 |
| Etirinotecan Pegol (NKTR-102) in NSCLC (NCT01773109) | Abramson Cancer Center at Penn Medicine | 2013-01-01 |
| A Study of the Communication of Genetic Test Results By Telephone: A Multi-Center Study (NCT01736345) | Abramson Cancer Center at Penn Medicine | 2012-12-03 |
| The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy (NCT02135679) | Abramson Cancer Center at Penn Medicine | 2012-09-01 |
| Autophagy Induction After Bortezomib for Myeloma (NCT01594242) | Abramson Cancer Center at Penn Medicine | 2012-07-10 |
| The Breast Program - Translational Cancer Resource (NCT02798341) | Abramson Cancer Center at Penn Medicine | 2012-07-01 |
| Functional MRI Use in Prostate Radiation Treatment Planning (NCT01985932) | Abramson Cancer Center at Penn Medicine | 2012-07-01 |
| Multi-peptide Vaccine With Basilixumab for Breast Cancer (NCT01660529) | Abramson Cancer Center at Penn Medicine | 2012-06-01 |
| CRLX101 Plus Bevacizumab in Advanced RCC (NCT01625936) | Abramson Cancer Center at Penn Medicine | 2012-06-01 |
| Dovitinib in Neuroendocrine Tumors (NCT01635907) | Abramson Cancer Center at Penn Medicine | 2012-06-01 |
| Ruxolitinib in Estrogen Receptor Positive Breast Cancer (NCT01594216) | Abramson Cancer Center at Penn Medicine | 2012-04-01 |
| Maintenance Lenalidomide in Lymphoma (NCT01575860) | Abramson Cancer Center at Penn Medicine | 2012-04-01 |
| Phase 1 Study of Preoperative Gemcitabine Plus CP-870, 893 Followed by Addition of CP-870,893 to Standard -Of-care Adjuvant Chemoradiation for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma (NCT01456585) | Abramson Cancer Center at Penn Medicine | 2012-04-01 |
| Proton Radiotherapy for Stage I, IIA, and IIB Seminoma (NCT01557790) | Abramson Cancer Center at Penn Medicine | 2012-03-01 |
| Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology (NCT01540695) | Abramson Cancer Center at Penn Medicine | 2012-02-01 |
| MLN8237 in Head and Neck Cancer (NCT01540682) | Abramson Cancer Center at Penn Medicine | 2012-02-01 |
| Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL) (NCT01676831) | Abramson Cancer Center at Penn Medicine | 2012-02-01 |
| Peripheral vs. Selective Tumor Marker Venous Sampling in Prostate Cancer (NCT02479945) | Abramson Cancer Center at Penn Medicine | 2012-01-01 |
| Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer (NCT01520038) | Abramson Cancer Center at Penn Medicine | 2012-01-01 |
| A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy (NCT01661166) | Abramson Cancer Center at Penn Medicine | 2012-01-01 |
| A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer (NCT01506973) | Abramson Cancer Center at Penn Medicine | 2011-12-01 |
| RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA (NCT01497808) | Abramson Cancer Center at Penn Medicine | 2011-11-29 |
| BETERNet Notch Signaling and Novel Biomarkers for Barretts Esophagus (NCT01484925) | Abramson Cancer Center at Penn Medicine | 2011-11-01 |
| Brivanib Metastatic Renal Cell Carcinoma (NCT01253668) | Abramson Cancer Center at Penn Medicine | 2011-11-01 |
| A Phase I-II Open Label Non-Randomized Study Using TL32711 for Patients With Acute Myelogenous Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia (NCT01486784) | Abramson Cancer Center at Penn Medicine | 2011-11-01 |
| Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma (NCT01510119) | Abramson Cancer Center at Penn Medicine | 2011-09-01 |
| Proton Radiotherapy for Upper Gastrointestinal Malignancies (NCT01449864) | Abramson Cancer Center at Penn Medicine | 2011-08-01 |
| DCE-MRI PET Bevacizumab Study in Rectal Cancer (NCT01426074) | Abramson Cancer Center at Penn Medicine | 2011-08-01 |
| Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project (NCT01452984) | Abramson Cancer Center at Penn Medicine | 2011-07-01 |
| Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases (NCT02159742) | Abramson Cancer Center at Penn Medicine | 2011-07-01 |
| Intraoperative Imaging of Breast Cancer With Indocyanine Green (NCT01796041) | Abramson Cancer Center at Penn Medicine | 2011-07-01 |
| Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine (NCT01396200) | Abramson Cancer Center at Penn Medicine | 2011-06-01 |
| Pelvic Floor Disorders in Survivors of Gynecologic Malignancies (NCT01370122) | Abramson Cancer Center at Penn Medicine | 2011-05-01 |
| Cardiovascular Effects of Sunitinib Therapy (CREST) (NCT01370109) | Abramson Cancer Center at Penn Medicine | 2011-04-01 |
| A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT01312389) | Abramson Cancer Center at Penn Medicine | 2011-04-01 |
| PD0332991/Paclitaxel in Advanced Breast Cancer (NCT01320592) | Abramson Cancer Center at Penn Medicine | 2011-03-01 |
| F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer (NCT01985971) | Abramson Cancer Center at Penn Medicine | 2011-03-01 |
| Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer (NCT01312376) | Abramson Cancer Center at Penn Medicine | 2011-03-01 |
| Effect of Donepezil on Smoking (NCT01250977) | Abramson Cancer Center at Penn Medicine | 2011-01-11 |
| The Effects of Radiation in Reconstructed Breasts (NCT01292772) | Abramson Cancer Center at Penn Medicine | 2010-12-01 |
| DIBH Proton Planning (NCT01386697) | Abramson Cancer Center at Penn Medicine | 2010-11-01 |
| Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC) (NCT01221506) | Abramson Cancer Center at Penn Medicine | 2010-10-01 |
| Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00568880) | Abramson Cancer Center at Penn Medicine | 2010-09-08 |
| Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy (NCT01548807) | Abramson Cancer Center at Penn Medicine | 2010-09-01 |
| Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study (NCT01212731) | Abramson Cancer Center at Penn Medicine | 2010-09-01 |
| FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer (NCT01206530) | Abramson Cancer Center at Penn Medicine | 2010-09-01 |
| A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy (NCT02130427) | Abramson Cancer Center at Penn Medicine | 2010-09-01 |
| BCRL Prevention Pilot (NCT01166672) | Abramson Cancer Center at Penn Medicine | 2010-07-01 |
| Cardiotoxicity of Cancer Therapy (CCT) (NCT01173341) | Abramson Cancer Center at Penn Medicine | 2010-07-01 |
| Eltrombopag in Elderly Acute Myelogenous Leukemia (AML) (NCT01113502) | Abramson Cancer Center at Penn Medicine | 2010-06-01 |
| Proton Radiotherapy for Extremity Soft Tissue Sarcoma (NCT01561495) | Abramson Cancer Center at Penn Medicine | 2010-06-01 |
| Physical Functional Side Effects of Taxane Chemotherapy for Breast Cancer (NCT01153282) | Abramson Cancer Center at Penn Medicine | 2010-06-01 |
| Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia (NCT00615784) | Abramson Cancer Center at Penn Medicine | 2010-05-25 |
| Autologous OC-DC Vaccine in Ovarian Cancer (NCT01132014) | Abramson Cancer Center at Penn Medicine | 2010-05-01 |
| LIVESTRONG Survivorship Care Plan: Continued Data Collection and Follow Up Survey (NCT02559323) | Abramson Cancer Center at Penn Medicine | 2010-05-01 |
| Combination Gene Transfer and Chemotherapy (NCT01119664) | Abramson Cancer Center at Penn Medicine | 2010-04-27 |
| Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma (NCT01112293) | Abramson Cancer Center at Penn Medicine | 2010-04-01 |
| Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC) (NCT01108666) | Abramson Cancer Center at Penn Medicine | 2010-03-01 |
| Proton Radiation for Chordomas and Chondrosarcomas (NCT01449149) | Abramson Cancer Center at Penn Medicine | 2010-03-01 |
| Proton Radiation For Meningiomas and Hemangiopericytomas (NCT01117844) | Abramson Cancer Center at Penn Medicine | 2010-02-04 |
| Tremelimumab and CP-870,893 in Patients With Metastatic Melanoma (NCT01103635) | Abramson Cancer Center at Penn Medicine | 2010-02-01 |
| Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples (NCT01985919) | Abramson Cancer Center at Penn Medicine | 2010-02-01 |
| Single Nucleotide Polymorphism (SNP) Panels and Risk Assessment in Women Undergoing Mammography (NCT01124019) | Abramson Cancer Center at Penn Medicine | 2010-02-01 |
| Proton Radiotherapy for Recurrent Tumors (NCT01126476) | Abramson Cancer Center at Penn Medicine | 2010-02-01 |
| Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery (NCT01076231) | Abramson Cancer Center at Penn Medicine | 2010-01-01 |
| Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas (NCT01024907) | Abramson Cancer Center at Penn Medicine | 2009-12-17 |
| Proton Beam Radiation Therapy in Treating Patients With Retroperitoneal Sarcoma (NCT01034566) | Abramson Cancer Center at Penn Medicine | 2009-11-01 |
| Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer (NCT01037790) | Abramson Cancer Center at Penn Medicine | 2009-10-01 |
| Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck (NCT01044433) | Abramson Cancer Center at Penn Medicine | 2009-10-01 |
| Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer (NCT01042041) | Abramson Cancer Center at Penn Medicine | 2009-09-01 |
| Proton Radiation Therapy in Treating Patients With Prostate Cancer (NCT01045226) | Abramson Cancer Center at Penn Medicine | 2009-08-01 |
| Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer (NCT01352429) | Abramson Cancer Center at Penn Medicine | 2009-08-01 |
| Magnetic Resonance Imaging-Based Radiation Therapy and Cisplatin in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer (NCT01016561) | Abramson Cancer Center at Penn Medicine | 2009-07-01 |
| DC Vaccine for Patients With Ductal Carcinoma In Situ (NCT02061332) | Abramson Cancer Center at Penn Medicine | 2009-07-01 |
| Magnetic Resonance Imaging in Evaluating Response to RadiationTherapy in Patients With High Grade Glioma (NCT01018329) | Abramson Cancer Center at Penn Medicine | 2009-07-01 |
| Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph Nodes (NCT01019278) | Abramson Cancer Center at Penn Medicine | 2009-07-01 |
| Flexitouch Lymphedema System in Treating Stage II Lymphedema in Patients With Breast Cancer (NCT01019512) | Abramson Cancer Center at Penn Medicine | 2009-07-01 |
| Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation (NCT00948753) | Abramson Cancer Center at Penn Medicine | 2009-06-01 |
| Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy (NCT01019187) | Abramson Cancer Center at Penn Medicine | 2009-06-01 |
| MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate (NCT01028885) | Abramson Cancer Center at Penn Medicine | 2009-06-01 |
| Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer (NCT01017133) | Abramson Cancer Center at Penn Medicine | 2009-05-01 |
| Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint Pain (NCT01013337) | Abramson Cancer Center at Penn Medicine | 2009-05-01 |